Clinical Trials Directory

Trials / Completed

CompletedNCT01691066

Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Yale University · Academic / Other
Sex
All
Age
12 Months – 15 Months
Healthy volunteers
Not accepted

Summary

The purpose of this study aims to investigate the utility of Pivotal Response Treatment (PRT), a behaviorally derived intervention, to improve the quality and frequency of communication and social engagement of toddlers with siblings who have an autism spectrum disorder (SIBS - ASD) and who demonstrate developmental delays and impairments in social interaction between 12 and 15 months of age.

Conditions

Interventions

TypeNameDescription
BEHAVIORALInfant Toddler Years PRT

Timeline

Start date
2012-09-01
Primary completion
2017-02-27
Completion
2017-02-27
First posted
2012-09-24
Last updated
2020-06-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01691066. Inclusion in this directory is not an endorsement.

Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder (NCT01691066) · Clinical Trials Directory